Orforglipron pepetide

Description

Orforglipron (Foundayo) is an oral weight loss treatment. It’s produced by Eli Lilly, the makers of Mounjaro injections.

Known under the brand name Foundayo in the US, orforglipron is designed to support weight management when used alongside a reduced-calorie diet and increased physical activity. It helps regulate appetite, making it easier to control your food intake and maintain healthier habits.

Orforglipron (Foundayo) is similar to the Wegovy pill, which is an oral GLP-1 weight loss medication.

Orforglipron, the active ingredient in Foundayo, works to help you feel fuller for longer, which may lead to reduced appetite and calorie intake. In the ATTAIN-1 clinical trials, patients using the Foundayo pill at the 17.2mg dose lost 11.2% body weight over 72 weeks.

While orforglipron (Foundayo) has been approved for use in the US, it’s currently awaiting approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before it can be used in the UK. Orgforglipron may be known under a different brand name if and when it becomes available in the UK.

If approved, you’ll be able to buy orforglipron (Foundayo) from UK-registered pharmacies, including The Independent Pharmacy, following an online consultation.